A. Carides

1.4k total citations
25 papers, 1.1k citations indexed

About

A. Carides is a scholar working on Surgery, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Carides has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 8 papers in Physiology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in A. Carides's work include Nausea and vomiting management (20 papers), Anesthesia and Pain Management (9 papers) and Pathogenesis and Treatment of Hiccups (6 papers). A. Carides is often cited by papers focused on Nausea and vomiting management (20 papers), Anesthesia and Pain Management (9 papers) and Pathogenesis and Treatment of Hiccups (6 papers). A. Carides collaborates with scholars based in United States, Netherlands and Denmark. A. Carides's co-authors include Judith K. Evans, Kevin Horgan, Jørn Herrstedt, Ronald de Wit, M. Elmer, Bernardo L. Rapoport, Paul J. Hesketh, Simon Van Belle, Christoph Schmidt and R.J. Naylor and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

A. Carides

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Carides United States 12 825 369 163 122 98 25 1.1k
Tomasz Jarzembowski United States 13 259 0.3× 67 0.2× 85 0.5× 90 0.7× 22 0.2× 25 537
Joseph Lau United States 8 79 0.1× 191 0.5× 57 0.3× 87 0.7× 43 0.4× 14 494
Oliver Kummer Switzerland 12 202 0.2× 57 0.2× 39 0.2× 37 0.3× 167 1.7× 15 441
Pin Zhang China 19 610 0.7× 318 0.9× 21 0.1× 24 0.2× 180 1.8× 68 999
B Walton United Kingdom 12 171 0.2× 33 0.1× 148 0.9× 87 0.7× 30 0.3× 27 547
Hasan Kara Türkiye 13 164 0.2× 41 0.1× 62 0.4× 26 0.2× 56 0.6× 46 469
Janet B. Arrowsmith United States 6 250 0.3× 35 0.1× 206 1.3× 28 0.2× 122 1.2× 6 726
Birger Fagher Sweden 16 144 0.2× 101 0.3× 12 0.1× 68 0.6× 38 0.4× 45 661
A. M. J. Woolfson United Kingdom 10 98 0.1× 171 0.5× 14 0.1× 25 0.2× 105 1.1× 19 615

Countries citing papers authored by A. Carides

Since Specialization
Citations

This map shows the geographic impact of A. Carides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Carides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Carides more than expected).

Fields of papers citing papers by A. Carides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Carides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Carides. The network helps show where A. Carides may publish in the future.

Co-authorship network of co-authors of A. Carides

This figure shows the co-authorship network connecting the top 25 collaborators of A. Carides. A scholar is included among the top collaborators of A. Carides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Carides. A. Carides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cheng, Yufeng, L. Zhang, Baohui Han, et al.. (2011). The effect of a 3-day oral aprepitant regimen on the prevention of CINV over standard therapy in Chinese patients receiving high-dose cisplatin.. Journal of Clinical Oncology. 29(15_suppl). 9105–9105. 2 indexed citations
3.
Grunberg, Steven M., Dtt Chua, Judith A. Boice, et al.. (2010). Phase III randomized double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting.. Journal of Clinical Oncology. 28(15_suppl). 9021–9021. 8 indexed citations
4.
Gralla, Richard J., Bernardo L. Rapoport, Karin Jordan, James C. Street, & A. Carides. (2010). Assessing the magnitude of antiemetic benefit with the addition of the NK1 receptor antagonist (NK1) aprepitant for all platinum agents: Analysis of 1,872 patients (pts) in prospective randomized clinical phase III trials (RCTs).. Journal of Clinical Oncology. 28(15_suppl). 9057–9057. 11 indexed citations
5.
6.
Diemunsch, Pierre, Tong J. Gan, B. K. Philip, et al.. (2007). Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery †. British Journal of Anaesthesia. 99(2). 202–211. 119 indexed citations
7.
Liu, K. S., Norman Heyden, A. Carides, et al.. (2007). Detection Bias Due to the Effect of Finasteride on Prostate Volume: A Modeling Approach for Analysis of the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 99(18). 1366–1374. 80 indexed citations
8.
9.
10.
Wit, Ronald de, Jørn Herrstedt, Bernardo L. Rapoport, et al.. (2004). The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.. PubMed. 40(3). 403–10. 119 indexed citations
11.
Gralla, Richard J., David Warr, A. Carides, Judith K. Evans, & Kevin Horgan. (2004). Effect of aprepitant on antiemetic protection in patients receiving moderately emetogenic chemotherapy plus high-dose cisplatin: Analysis of combined data from 2 phase III randomized clinical trials. Journal of Clinical Oncology. 22(14_suppl). 8137–8137. 1 indexed citations
12.
Gralla, Richard J., David Warr, A. Carides, Judith K. Evans, & Kevin Horgan. (2004). Effect of aprepitant on antiemetic protection in patients receiving moderately emetogenic chemotherapy plus high-dose cisplatin: Analysis of combined data from 2 phase III randomized clinical trials. Journal of Clinical Oncology. 22(14_suppl). 8137–8137. 4 indexed citations
13.
Hesketh, Paul J., Simon Van Belle, Matti Aapro, et al.. (2003). Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European Journal of Cancer. 39(8). 1074–1080. 208 indexed citations
14.
Carides, A., Jay D. Pearson, Kevin Horgan, et al.. (2003). Functional relevance of antiemetic control. European Journal of Cancer. 39(10). 1395–1401. 50 indexed citations
15.
Horgan, Kevin, Steven M. Grunberg, Paul J. Hesketh, et al.. (2003). 945 Analysis of pooled data from two Phase III studies of the NK-1 antagonist aprepitant to assess relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting. European Journal of Cancer Supplements. 1(5). S284–S285. 5 indexed citations
16.
Carides, A., et al.. (2003). 937 Superiority of aprepitant, an oral NK1 antagonist, over standard antiemetic therapy: Reducing the impact of nausea and vomiting on patients' daily lives. European Journal of Cancer Supplements. 1(5). S282–S282. 2 indexed citations
17.
Wit, Ronald de, Jørn Herrstedt, Bernardo L. Rapoport, et al.. (2003). Addition of the Oral NK1 Antagonist Aprepitant to Standard Antiemetics Provides Protection Against Nausea and Vomiting During Multiple Cycles of Cisplatin-Based Chemotherapy. Journal of Clinical Oncology. 21(22). 4105–4111. 116 indexed citations
18.
Cocquyt, V., Simon Van Belle, Robert Reinhardt, et al.. (2001). Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. European Journal of Cancer. 37(7). 835–842. 116 indexed citations
19.
Cantilena, Louis R., Jacqueline B. McCrea, Gregory A. Winchell, et al.. (1999). Lack of a pharmacokinetic interaction between indinavir and methadone. Clinical Pharmacology & Therapeutics. 65(2). 135–135. 19 indexed citations
20.
McCrea, Jacqueline B., et al.. (1997). Pharmacokinetic interaction between indinavir and rifampin. Clinical Pharmacology & Therapeutics. 61(2). 152. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomasz Jarzembowski Breakdown of academic impact, for papers by Joseph Lau Breakdown of academic impact, for papers by Oliver Kummer Breakdown of academic impact, for papers by Pin Zhang Breakdown of academic impact, for papers by B Walton Breakdown of academic impact, for papers by Hasan Kara Breakdown of academic impact, for papers by Janet B. Arrowsmith Breakdown of academic impact, for papers by Birger Fagher Breakdown of academic impact, for papers by A. M. J. Woolfson
Rankless by CCL
2026